(Q33954645)

30 July 2017

ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES. (English)

1 reference

30 July 2017

0 references

FLETCHER AP

1

1 reference

30 July 2017

BIEDERMAN O

2

1 reference

30 July 2017

MOORE D

3

1 reference

30 July 2017

ALKJAERSIG N

4

1 reference

30 July 2017

SHERRY S

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 April 1964

1 reference

Journal of Clinical Investigation

30 July 2017

1 reference

30 July 2017

43

1 reference

30 July 2017

681-695

1 reference

Studies on the thrombolytic activity of human plasma

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=289545

Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=289545

Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=289545

Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=289545

The maintenance of a sustained thrombolytic state in man. I. Induction and effects

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=289545

The mechanism of clot dissolution by plasmin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=289545

Studies on enhanced fibrinolytic activity in man.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=289545

The clearance of heterologous protein from the circulation of normal and immunized man

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=289545

An accelerating property of plasma for the coagulation of fibrinogen by thrombin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=289545

Fibrinolysis induced by pressor amines

5 July 2018

1 reference

12 December 2020

Measurement of extrahepatic shunted blood flow in liver cirrhosis

1 reference

12 December 2020

Fibrinolytic mechanisms and the development of thrombolytic therapy

1 reference

12 December 2020

Generalized excessive oozing in patients undergoing major surgery and receiving multiple blood transfusions

1 reference

12 December 2020

Plasma fibrinolytic activity in cirrhosis of the liver

1 reference

12 December 2020

On plasma fibrinolytic activity in cryptogenetic splenomegaly

1 reference

12 December 2020

Influence of some vasoactive drugs on fibrinolytic activity

1 reference

12 December 2020

The proactivator of the fibrinolytic system in human plasma. The quantitative determination and its clinical application

1 reference

12 December 2020

Coagulation defects in patients with cirrhosis of the liver undergoing portasystemic shunts

1 reference

12 December 2020

Effects of intravenous injections of the anticoagulant fraction of incubated fibrinogen on blood coagulation

1 reference

12 December 2020

Antifibrinolytic activity in primary carcinoma of the liver

1 reference

12 December 2020

The effect of hepatic lobectomy on some blood clotting factors and on fibrinolysis

1 reference

12 December 2020

Plasma Clotting Factors in Chronic Hepatocellular Disease

1 reference

12 December 2020

FIBRINOLYTIC ACTIVITY IN CIRRHOSIS OF THE LIVER

1 reference

12 December 2020

Studies on spontaneous fibrinolytic activity in patients with cirrhosis of the liver and its inhibition by epsilon amino caproic acid

1 reference

12 December 2020

Inhibition of fibrin polymerization by fibrinogen proteolysis products

1 reference

12 December 2020

[A new anticoagulant derived from fibrinogen]

1 reference

12 December 2020

A comparison of the fibrinolytic and fibrinogenolytic effects of plasminogen activators and proteolytic enzymes in plasma

1 reference

12 December 2020

Coagluation disturbances with manifest bleeding in extrahepatic portal hypertension and in liver cirrhosis. Preliminary results of heparin treatment

1 reference

12 December 2020

Coagulation defects in liver disease and response to transfusion during surgery

1 reference

12 December 2020

Fibrinolysis and fibrinolytic activity in man

1 reference

12 December 2020

THE FIBRINOLYTIC RESPONSE TO NICOTINIC ACID IN ABNORMAL LIVER STATES

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI104953

1 reference

30 July 2017

1 reference

30 July 2017

1 reference